Lindbrook Capital, LLC - EVOKE PHARMA INC ownership

EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 22 filers reported holding EVOKE PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of EVOKE PHARMA INC
ValueSharesWeighting
Q1 2022$0
-100.0%
1,0000.0%0.00%
Q4 2021$1,0000.0%1,0000.0%0.00%
Q3 2021$1,0000.0%1,0000.0%0.00%
Q2 2021$1,000
-50.0%
1,0000.0%0.00%
Q1 2021$2,000
-33.3%
1,0000.0%0.00%
-100.0%
Q4 2020$3,000
-40.0%
1,0000.0%0.00%0.0%
Q3 2020$5,000
+25.0%
1,0000.0%0.00%0.0%
Q2 2020$4,000
+300.0%
1,0000.0%0.00%
Q1 2020$1,000
-50.0%
1,0000.0%0.00%
-100.0%
Q4 2019$2,000
+100.0%
1,0000.0%0.00%
Q3 2019$1,0001,0000.0%0.00%
Q2 2019$0
-100.0%
1,0000.0%0.00%
Q1 2019$1,000
-50.0%
1,0000.0%0.00%
-100.0%
Q4 2018$2,0001,0000.00%
Other shareholders
EVOKE PHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Wambolt & Associates, LLC 33,165$29,0000.02%
STATE OF MICHIGAN RETIREMENT SYSTEM 400,000$344,0000.00%
A.R.T. Advisors, LLC 36,954$32,0000.00%
NORTHERN TRUST CORP 33,997$29,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 199,678$171,0000.00%
CITIGROUP INC 500$00.00%
MORGAN STANLEY 1,450$1,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 36,700$32,0000.00%
BlackRock Inc. 54,940$47,0000.00%
View complete list of EVOKE PHARMA INC shareholders